Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2025 Filed Jun 27, 2025 21:25 UTC |
Silverman JoshuaDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001140361-25-024006 · form4.xml · derivative · entry 1 Silverman Joshua · CIK 0001524858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-06-25 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 23, 2025 Filed Jul 1, 2025 16:57 UTC |
Nicholas Kelley StinsonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001140361-25-024398 · form4.xml · derivative · entry 1 Nicholas Kelley Stinson · CIK 0002075383 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on June 23, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 19:51 UTC |
Elefant DovChief Financial Officer
|
OtherCommon Stock | 19,608 | $1.02 | $20,000.16 |
DisclosureSEC source: 0001140361-25-021410 · form4.xml · nonDerivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,608 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 19:51 UTC |
Larsen CharlesDirector
|
OtherCommon stock | 24,510 | $1.02 | $25,000.20 |
DisclosureSEC source: 0001140361-25-021412 · form4.xml · nonDerivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55.986 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 19:51 UTC |
Currie Daniel ScottChief Operating Officer
|
OtherCommon Stock | 19,608 | $1.02 | $20,000.16 |
DisclosureSEC source: 0001140361-25-021411 · form4.xml · nonDerivative · entry 1 Currie Daniel Scott · CIK 0001857163 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,275 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 19:51 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
OtherCommon Stock | 34,314 | $1.02 | $35,000.28 |
DisclosureSEC source: 0001140361-25-021409 · form4.xml · nonDerivative · entry 1 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,092 Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:33 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 262,700 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001140361-25-002474 · form4.xml · derivative · entry 3 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,700 Underlying: Common Stock · 262,700 shares Expires 2035-01-29 F2 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on January 29, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:33 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,353 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001140361-25-002474 · form4.xml · derivative · entry 2 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,353 Underlying: Common Stock · 120,353 shares Expires 2035-01-29 Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:33 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 59,849 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001140361-25-002474 · form4.xml · derivative · entry 1 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,849 Underlying: Common Stock · 59,849 shares Expires 2035-01-29 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 3 years beginning on January 29, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 114,300 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002475 · form4.xml · derivative · entry 2 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,300 Underlying: Common Stock · 114,300 shares Expires 2035-01-28 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 72,045 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002475 · form4.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,045 Underlying: Common Stock · 72,045 shares Expires 2035-01-28 Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Currie Daniel ScottChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,700 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002477 · form4.xml · derivative · entry 3 Currie Daniel Scott · CIK 0001857163 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,700 Underlying: Common Stock · 140,700 shares Expires 2035-01-28 F2 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Currie Daniel ScottChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 59,313 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002477 · form4.xml · derivative · entry 2 Currie Daniel Scott · CIK 0001857163 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,313 Underlying: Common Stock · 59,313 shares Expires 2035-01-28 Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Currie Daniel ScottChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 29,184 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002477 · form4.xml · derivative · entry 1 Currie Daniel Scott · CIK 0001857163 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,184 Underlying: Common Stock · 29,184 shares Expires 2035-01-28 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Thomas Christine EChief Reg & Clinical Officer
|
GrantStock Option (Right to Buy) · Derivative | 23,600 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002476 · form4.xml · derivative · entry 3 Thomas Christine E · CIK 0001950745 · Chief Reg & Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,600 Underlying: Common Stock · 23,600 shares Expires 2035-01-28 F2 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Thomas Christine EChief Reg & Clinical Officer
|
GrantStock Option (Right to Buy) · Derivative | 28,682 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002476 · form4.xml · derivative · entry 2 Thomas Christine E · CIK 0001950745 · Chief Reg & Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,682 Underlying: Common Stock · 28,682 shares Expires 2035-01-28 Read SEC document |
| January 28, 2025 Filed Jan 31, 2025 00:33 UTC |
Thomas Christine EChief Reg & Clinical Officer
|
GrantStock Option (Right to Buy) · Derivative | 55,090 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001140361-25-002476 · form4.xml · derivative · entry 1 Thomas Christine E · CIK 0001950745 · Chief Reg & Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,090 Underlying: Common Stock · 55,090 shares Expires 2035-01-28 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:39 UTC |
Silverman JoshuaDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001140361-24-033183 · form4.xml · derivative · entry 1 Silverman Joshua · CIK 0001524858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2034-07-12 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:37 UTC |
Larsen CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001140361-24-033181 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2034-07-12 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:34 UTC |
Milnes AlistairDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001140361-24-033178 · form4.xml · derivative · entry 1 Milnes Alistair · CIK 0001901321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2034-07-12 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:33 UTC |
Uzialko Edward RDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001140361-24-033174 · form4.xml · derivative · entry 1 Uzialko Edward R · CIK 0001856783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2034-07-12 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 02:47 UTC |
Spector Richard D.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001140361-24-007609 · form4.xml · derivative · entry 1 Spector Richard D. · CIK 0002010688 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 12, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:43 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001140361-24-005353 · form4.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2034-02-01 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:43 UTC |
Currie Daniel ScottChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 61,900 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001140361-24-005354 · form4.xml · derivative · entry 1 Currie Daniel Scott · CIK 0001857163 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,900 Underlying: Common Stock · 61,900 shares Expires 2034-02-01 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:42 UTC |
Thomas Christine ESVP, Regulatory & Clinical
|
GrantStock Option (Right to Buy) · Derivative | 32,600 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001140361-24-005352 · form4.xml · derivative · entry 1 Thomas Christine E · CIK 0001950745 · SVP, Regulatory & Clinical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,600 Underlying: Common Stock · 32,600 shares Expires 2034-02-01 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:42 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 204,900 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001140361-24-005351 · form4.xml · derivative · entry 1 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,900 Underlying: Common Stock · 204,900 shares Expires 2034-02-01 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:39 UTC |
Silverman JoshuaDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001140361-23-054461 · form4.xml · derivative · entry 1 Silverman Joshua · CIK 0001524858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-11-21 F1 · derivative.exercise_date: The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on November 21, 2024, assuming continued service. Read SEC document |
| October 10, 2023 Filed Nov 2, 2023 01:40 UTC |
Thomas Christine ESVP, Regulatory & Clinical
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001140361-23-050942 · form4.xml · derivative · entry 1 Thomas Christine E · CIK 0001950745 · SVP, Regulatory & Clinical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-10-10 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 204,700 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032847 · form4.xml · derivative · entry 2 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,700 Underlying: Common Stock · 204,700 shares Expires 2033-07-03 Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 105,200 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032847 · form4.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,200 Underlying: Common Stock · 105,200 shares Expires 2033-07-03 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years from the date of grant, assuming continued employment. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 271,900 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032845 · form4.xml · derivative · entry 2 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,900 Underlying: Common Stock · 271,900 shares Expires 2033-07-03 Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Lee-Sepsick KathyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 270,400 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032845 · form4.xml · derivative · entry 1 Lee-Sepsick Kathy · CIK 0001857109 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,400 Underlying: Common Stock · 270,400 shares Expires 2033-07-03 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years from the date of grant, assuming continued employment. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Currie Daniel ScottSenior VP, Operations
|
GrantStock Option (Right to Buy) · Derivative | 124,800 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032846 · form4.xml · derivative · entry 2 Currie Daniel Scott · CIK 0001857163 · Senior VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,800 Underlying: Common Stock · 124,800 shares Expires 2033-07-03 Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 22:00 UTC |
Currie Daniel ScottSenior VP, Operations
|
GrantStock Option (Right to Buy) · Derivative | 84,600 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001140361-23-032846 · form4.xml · derivative · entry 1 Currie Daniel Scott · CIK 0001857163 · Senior VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,600 Underlying: Common Stock · 84,600 shares Expires 2033-07-03 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years from the date of grant, assuming continued employment. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 16:15 UTC |
Morrissey AnneDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001140361-23-031166 · form4.xml · derivative · entry 1 Morrissey Anne · CIK 0001866404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:15 UTC |
Perrow WendyDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001140361-23-031164 · form4.xml · derivative · entry 1 Perrow Wendy · CIK 0001660814 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:15 UTC |
Larsen CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001140361-23-031165 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:15 UTC |
Uzialko Edward RDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001140361-23-031163 · form4.xml · derivative · entry 1 Uzialko Edward R · CIK 0001856783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 16:41 UTC |
Kendall Keith JDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $0.64 | $0.00 |
DisclosureSEC source: 0001140361-23-030281 · form4.xml · derivative · entry 1 Kendall Keith J · CIK 0001406834 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on June 14, 2024, assuming continued service. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:42 UTC |
Milnes AlistairDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $0.64 | $0.00 |
DisclosureSEC source: 0001140361-23-030284 · form4.xml · derivative · entry 1 Milnes Alistair · CIK 0001901321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-14 F1 · derivative.exercise_date: The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on June 14, 2024, assuming continued service. Read SEC document |
| October 10, 2022 Filed Oct 17, 2022 20:48 UTC |
Thomas Christine ESVP, Regulatory & Clinical
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-22-037412 · form4.xml · derivative · entry 1 Thomas Christine E · CIK 0001950745 · SVP, Regulatory & Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-10-10 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2023, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 18:19 UTC |
Morrissey AnneDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022652 · form4.xml · derivative · entry 1 Morrissey Anne · CIK 0001866404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC |
Dyett JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022654 · form4.xml · derivative · entry 1 Dyett John · CIK 0001610631 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC |
Perrow WendyDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022653 · form4.xml · derivative · entry 1 Perrow Wendy · CIK 0001660814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC |
Larsen CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022651 · form4.xml · derivative · entry 1 Larsen Charles · CIK 0001857458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC |
Adams John Q JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022650 · form4.xml · derivative · entry 1 Adams John Q JR · CIK 0001856775 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC |
Uzialko Edward RDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022649 · form4.xml · derivative · entry 1 Uzialko Edward R · CIK 0001856783 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:38 UTC |
Elefant DovChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001140361-22-007350 · form4.xml · derivative · entry 1 Elefant Dov · CIK 0001326487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: The shares underlying the stock option vest equally in installments over 4 years beginning on February 28, 2023, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date. Read SEC document |
| January 25, 2022 Filed Jan 28, 2022 02:12 UTC |
Currie Daniel ScottSenior VP, Operations
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001140361-22-002956 · form4.xml · derivative · entry 1 Currie Daniel Scott · CIK 0001857163 · Senior VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-01-25 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Equity Incentive Plan. F2 · derivative.exercise_date: The shares underlying the stock options vest equally in installments over 4 years beginning on January 25, 2022. Read SEC document |
| January 25, 2022 Filed Jan 28, 2022 02:10 UTC |
Perrow WendyDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001140361-22-002954 · form4.xml · derivative · entry 1 Perrow Wendy · CIK 0001660814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2032-01-25 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Equity Incentive Plan. F2 · derivative.exercise_date: The shares underlying the stock options vest equally in installments over 3 years beginning on January 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.